QR-Code

Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing

Abstract Chimeric antigen receptor-modified T cells (CAR-T cells) have shown good effects in the treatment of hematologic cancers; however, they may cause on-target off-tumor toxicity because of minimal expression of tumor-associated antigens (TAAs) on normal tissues, particularly in the context of...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Qibin Liao, Huan He, Yunyu Mao, Xiangqing Ding, Xiaoyan Zhang, Jianqing Xu
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2020-10-01
Schriftenreihe:Biomarker Research
Schlagworte:
Online-Zugang:http://link.springer.com/article/10.1186/s40364-020-00238-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!